Pharmaceutical Innovations: Superior Position of the USA and Weaknesses of German Research
Abstract The innovative strength of research performance is often measured in terms of inputs such as research funds or outputs such as patent applications. We present a novel indicator of pharmaceutical innovativeness that focuses on global medical breakthroughs and associated patents. According to...
Saved in:
Main Authors: | Andreas Eckert, Wolfgang Maennig |
---|---|
Format: | Article |
Language: | deu |
Published: |
Sciendo
2021-08-01
|
Series: | Wirtschaftsdienst |
Online Access: | https://doi.org/10.1007/s10273-021-2985-3 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
INNOVATIVE PROCESSES IN THE RUSSIAN PHARMACEUTICAL MARKET
by: E. A. Bykova
Published: (2020-09-01) -
ROLE OF INNOVATIVE CLUSTERS IN DEVELOPMENT OF NATIONAL ECONOMY OF THE USA
by: A. Akopyan
Published: (2016-06-01) -
Insolvent Local Government: German Approaches to Prevention
by: Thomas Duve, et al.
Published: (2011-06-01) -
The Role of Pharmaceutical Innovation in Clinical Practice Guidelines for Chronic Diseases
by: Meaghan Roach, et al.
Published: (2024-01-01) -
Innovations in pharmaceutical policies and learnings for sustainable access to affordable medicines
by: Sabine Vogler, et al.
Published: (2024-04-01)